|
[1] W. A. Wilson et al., "International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop," (in eng), Arthritis Rheum, vol. 42, no. 7, pp. 1309-11, Jul 1999, doi: 10.1002/1529-0131(199907)42:7<1309::Aid-anr1>3.0.Co;2-f. [2] M. D. Lockshin, L. R. Sammaritano, and S. Schwartzman, "Validation of the Sapporo criteria for antiphospholipid syndrome," (in eng), Arthritis Rheum, vol. 43, no. 2, pp. 440-3, Feb 2000, doi: 10.1002/1529-0131(200002)43:2<440::Aid-anr26>3.0.Co;2-n. [3] S. Miyakis et al., "International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)," (in eng), J Thromb Haemost, vol. 4, no. 2, pp. 295-306, Feb 2006, doi: 10.1111/j.1538-7836.2006.01753.x. [4] C. J. Edwards and G. R. Hughes, "Hughes syndrome (the antiphospholipid syndrome): 25 years old," (in eng), Mod Rheumatol, vol. 18, no. 2, pp. 119-24, 2008, doi: 10.1007/s10165-008-0042-3. [5] W. A. Wilson et al., "International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop," Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, vol. 42, no. 7, pp. 1309-1311, 1999. [6] S. Miyakis et al., "International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)," Journal of Thrombosis and Haemostasis, vol. 4, no. 2, pp. 295-306, 2006. [7] R. A. Asherson, S. Bucciarelli, J. A. Gómez-Puerta, and R. Cervera, "Chapter 1 History, Classification, and Subsets of the Antiphospholipid Syndrome," in Handbook of Systemic Autoimmune Diseases, vol. 10, R. Cervera, J. C. Reverter, and M. Khamashta Eds.: Elsevier, 2009, pp. 1-11. [8] S. Kanaya, M. Altaf-Ul-Amin, S. K. Kiboi, and F. M. Afendi, "Big Data and Network Biology 2015," Biomed Res Int, vol. 2015, p. 604623, 2015, doi: 10.1155/2015/604623. [9] T. Mehta, M. Hussain, K. Sheth, Y. Ding, and L. D. McCullough, "Risk of hemorrhagic transformation after ischemic stroke in patients with antiphospholipid antibody syndrome," (in eng), Neurol Res, vol. 39, no. 6, pp. 477-483, Jun 2017, doi: 10.1080/01616412.2017.1323382. [10] J. Alijotas-Reig et al., "The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases," (in eng), Autoimmun Rev, vol. 14, no. 5, pp. 387-95, May 2015, doi: 10.1016/j.autrev.2014.12.010. [11] N. Heikal et al., "Laboratory Evaluation of Antiphospholipid Syndrome," (in eng), Am J Clin Pathol, Jul 15 2019, doi: 10.1093/ajcp/aqz085. [12] L. Vanoverschelde, H. Kelchtermans, J. Musial, B. de Laat, and K. M. J. Devreese, "Influence of anticardiolipin and anti-beta2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification," (in eng), Res Pract Thromb Haemost, vol. 3, no. 3, pp. 515-527, Jul 2019, doi: 10.1002/rth2.12207. [13] B. B. Suh-Lailam, A. Cromar, K. W. Davis, and A. E. Tebo, "APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome," (in eng), Int J Clin Exp Pathol, vol. 5, no. 3, pp. 210-5, 2012. [14] E. Harris et al., "Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus," The Lancet, vol. 322, no. 8361, pp. 1211-1214, 1983. [15] L. K. Peterson, R. Willis, E. N. Harris, W. D. Branch, and A. E. Tebo, "Antibodies to Phosphatidylserine/Prothrombin Complex in Antiphospholipid Syndrome: Analytical and Clinical Perspectives," (in eng), Adv Clin Chem, vol. 73, pp. 1-28, 2016, doi: 10.1016/bs.acc.2015.10.003. [16] K. Stadler et al., "Therapeutic challenges after successful thrombectomy in a patient with an antiphospholipid syndrome associated M1-occlusion: A case report," Interventional Neuroradiology, vol. 21, no. 5, pp. 598-602, 2015, doi: 10.1177/1591019915590371. [17] E. N. Harris and S. S. Pierangeli, "Primary, Secondary, Catastrophic Antiphospholipid Syndrome: is there a difference?," (in eng), Thromb Res. , no. 0049-3848 (Print), 20041027 DCOM- 20050414 2004. [18] R. Cervera, "Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry'," (in eng), Lupus, vol. 19, no. 4, pp. 412-8, Apr 2010, doi: 10.1177/0961203309361353. [19] C. J. Edwards et al., "The presence of anticardiolipin antibodies in adults may be influenced by infections in infancy," (in eng), Qjm, vol. 101, no. 1, pp. 41-7, Jan 2008, doi: 10.1093/qjmed/hcm119. [20] F. Grimaud et al., "Clinical and immunological features of antiphospholipid syndrome in the elderly: a retrospective national multicentre study," (in eng), Rheumatology (Oxford), vol. 58, no. 6, pp. 1006-1010, Jun 1 2019, doi: 10.1093/rheumatology/key437. [21] A. F. Saad, L. T. Nickell, R. E. Heithaus, S. A. Shamim, M. J. Opatowsky, and K. F. Layton, "Basilar artery thrombosis in the setting of antiphospholipid syndrome," Proceedings (Baylor University. Medical Center), vol. 27, no. 3, pp. 210-212, 2014. [Online]. Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059565/. [22] M. D. Lockshin, "Future trends for treatment of APS," (in eng), J Autoimmun, vol. 15, no. 2, pp. 261-4, Sep 2000, doi: 10.1006/jaut.2000.0406. [23] R. C. M.-C. B. M. K. G. Hughes, "," Lupus, vol. Vol 18, no. 10, 2009. [24] A. E. Harris En Fau - Gharavi et al., "Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus," (in eng), no. 0140-6736 (Print), 19840127 DCOM- 19840127 1983. [25] E. N. Harris, G. R. Asherson Ra Fau - Hughes, and G. R. Hughes, "Antiphospholipid antibodies--autoantibodies with a difference," (in eng), no. 0066-4219 (Print), 19880613 DCOM- 19880613 1988. [26] D. Erkan, Y. Yazici, R. Sobel, and M. D. Lockshin, "Primary antiphospholipid syndrome: functional outcome after 10 years," (in eng), J Rheumatol, vol. 27, no. 12, pp. 2817-21, Dec 2000. [27] N. Guballa, L. Sammaritano, S. Schwartzman, J. Buyon, and M. D. Lockshin, "Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome," (in eng), Arthritis Rheum, vol. 43, no. 3, pp. 550-6, Mar 2000, doi: 10.1002/1529-0131(200003)43:3<550::Aid-anr10>3.0.Co;2-y. [28] E. C. Somers and W. Marder, "Infertility - Prevention and Management," (in eng), Rheum Dis Clin North Am, vol. 43, no. 2, pp. 275-285, May 2017, doi: 10.1016/j.rdc.2016.12.007. [29] P. Orquevaux et al., "In Vitro Fertilization in 37 Women with Systemic Lupus Erythematosus or Antiphospholipid Syndrome: A Series of 97 Procedures," (in eng), J Rheumatol, vol. 44, no. 5, pp. 613-618, May 2017, doi: 10.3899/jrheum.160462. [30] M. L. McHugh, "The chi-square test of independence," Biochemia medica: Biochemia medica, vol. 23, no. 2, pp. 143-149, 2013. [31] I. Jolliffe, "Principal Component Analysis," in International Encyclopedia of Statistical Science, M. Lovric Ed. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011, pp. 1094-1096. [32] S. Wold, K. Esbensen, and P. Geladi, "Principal component analysis," Chemometrics and Intelligent Laboratory Systems, vol. 2, no. 1, pp. 37-52, 1987/08/01/ 1987, doi: https://doi.org/10.1016/0169-7439(87)80084-9. [33] F. B. Bryant and P. R. Yarnold, "Principal-components analysis and exploratory and confirmatory factor analysis," in Reading and understanding multivariate statistics. Washington, DC, US: American Psychological Association, 1995, pp. 99-136. [34] A. Satorra and P. M. Bentler, "A scaled difference chi-square test statistic for moment structure analysis," Psychometrika, journal article vol. 66, no. 4, pp. 507-514, December 01 2001, doi: 10.1007/bf02296192. [35] G. Chen and N. Balakrishnan, "A general purpose approximate goodness-of-fit test," Journal of Quality Technology, vol. 27, no. 2, pp. 154-161, 1995. [36] A. R. Hakstian and T. E. Whalen, "A k-sample significance test for independent alpha coefficients," Psychometrika, vol. 41, no. 2, pp. 219-231, 1976. [37] D. Bartholomew, "A test of homogeneity for ordered alternatives," Biometrika, vol. 46, no. 1/2, pp. 36-48, 1959. [38] S. Vyas and L. Kumaranayake, "Constructing socio-economic status indices: how to use principal components analysis," Health Policy and Planning, vol. 21, no. 6, pp. 459-468, 2006, doi: 10.1093/heapol/czl029.
|